Tacrolimus
- Product NDC
- 42291-754
- 11-digit product format
- 422910754
- Labeler code
- 42291
- Product ID
- 42291-754_d4c99e82-d744-4788-e053-2995a90a2368
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tacrolimus Capsules
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- AvKARE
- Application
- ANDA206651
- Marketing category
- ANDA
- Marketing start
- 2020-03-19
- Marketing end
- 0000-00-00
- Substance
- TACROLIMUS
- Active strength
- 5 mg/1
- Pharmacologic classes
- Calcineurin Inhibitor Immunosuppressant [EPC],Calcineurin Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 42291-754-01 | 42291075401 | 100 CAPSULE in 1 BOTTLE (42291-754-01) | 100 capsule | 2020-03-19 | 0000-00-00 | No | No | Current |